- Description
- Specifications
Catalog #: CYT-527
Description:
VEGF-C Human Recombinant- contains 129 amino acids residues and was fused to a His- tag (6x His) at the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa protein in SDS-PAGE under reducing conditions.
Synonyms:
VEGF-C, Vascular endothelial growth factor C, VRP, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein, VEGFC.
Source:
Sf9, Insect Cells.
Purity:
Greater than 90.0% as determined by(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Solubility:
It is recommended to reconstitute the lyophilized VEGF-C in sterile 18MΩ–cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions.
Formulation:
Each mg of VEGF-C Human contains 50mg BSA and 1xPBS as buffer.
Stability:
Lyophilized VEGF-C although stable at room temperature for 3 weeks, should be stored desiccated below -18 °C. Upon reconstitution VEGF-C should be stored at 4 °C between 2-7 days and for future use below
-18 °C.
Please prevent freeze-thaw cycles.
Activity:
Measured by its ability to bind to the VEGFR-3/FLT-4 receptor in the Ba/F3-hVEGFR-3 assay. The ED50 in this assay is about 4ng/ml corresponding to a Specific Activity of 250,000IU/mg.
Physical Appearance:
Sterile Filtered White lyophilized (freeze-dried) powder.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
